31 Oct

WASHINGTON (Oct. 31, 2018) – Due to their broad antitumor activity that inhibits the function of microtubules, taxanes are common chemotherapeutic agents utilized for the management of multiple cancer types from breast to prostate. Unfortunately, the frequency of their use is equally matched by...


01 Oct

Adam Friedman, MD, is the senior author of a study on the efficacy of nanoparticles in therapies for triple-negative breast cancer.


27 Sep

WASHINGTON (Sept. 26, 2018) – Rong Li, PhD, will serve as chair of the Department of Biochemistry and Molecular Medicine at the George Washington University (GW) School of Medicine and Health Sciences. He will also serve as a professor in the...


24 Sep

Dr. Adam Friedman joins breast cancer survivor Mariam Said to discuss side effects of cancer treatment and how the Supportive Oncodermatology Clinic at the GW Cancer Center is giving patients hope and resources for relief.


11 Sep

Norman Lee, PhD, is investigating the mechanism behind dysregulation splicing factor expression.


05 Jun

Researchers from the George Washington University (GW) Cancer Center recently participated in the American Society of Clinical Oncology (ASCO) Annual Meeting held June 1-5, 2018 in Chicago. At the meeting, Robert Siegel, MD, associate center director for education and training at the GW Cancer...


27 Apr

Research published in Cancer Cell by George Washington University (GW) Cancer Center researcher Alexandros Tzatsos, MD, PhD, found an important connection between the KDM6A gene and the most aggressive form of pancreatic cancer.


26 Jan

Rohan Fernandes, PhD, assistant professor of medicine at the George Washington University School of Medicine and Health Sciences, received more than $700,000 from the Alex’s Lemonade Stand Foundation to research treatment for neuroblastoma, a childhood cancer that forms in certain types of nerve...


17 Jul

A team of researchers at GW Cancer Center found that T-cells lacking in the HDAC11 enzyme performed better in attacking cancer tumor cells. This research highlights the importance of treating HDAC11 as an immunotherapeutic target.


30 Jun

Norman Lee, PhD, professor of pharmacology and physiology, published research in Nature Communications finding that a form of genetic variation, called differential RNA splicing, may have a role in tumor aggressiveness and drug resistance in African American men with prostate cancer.


22 Jun

When chronic, unresponsive eruptions don't respond to standard treatments, think cutaneous T-cell lymphoma, says L. Frank Glass, MD in an interview with Adam Friedman, MD.


14 Jun

WASHINGTON (June 14, 2017) — Today some patients suffering with mantle cell lymphoma, a type of blood cancer, can be treated with a pill called ibrutinib, forgoing conventional chemotherapy. However, many are developing a resistance to this treatment. Research published in Nature Communications...


07 Apr

Adam Friedman, M.D., Associate Professor of Dermatology at the GW School of Medicine and Health Sciences, wrote an article for the Huffington Post on avoiding ultraviolet radiation.

...


16 Nov

George Washington University (GW) researchers received a $2.2 million grant from the National Cancer Institute to uncover why certain cancer types increase whereas others are unchanged or even decrease in those with HIV infection.